Patients, pharmacists and physicians are reporting a strained supply of Zepbound, Eli Lilly’s new weight loss drug, as the drugmaker and the FDA say the medication is available, according to Bloomberg.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
